51 / 154
377
bevacizumab: a multi-center study. Journal of Neuro-
Oncology 2012; 108(3): 491–498.
http://doi.org/10.1007/s11060-012-0847-y
44. Majós C. Proton MR spectroscopy provides relevant prognostic
information in high grade gliomas. AJNR Am. J. Neuroradiol
2011; 32: 74–80.
45. Saraswathy S., Crawford F., Lamborn K., Pirzkall A., Chang
S., Cha S., Nelson, S. Evaluation of MR markers that predict
survival in patients with newly diagnosed GBM prior to
adjuvant therapy. Journal of Neuro-Oncology 2009; 91(1):
69–81.
http://doi.org/10.1007/s11060-008-9685-346. Quon H. Changes in serial magnetic resonance spectroscopy
predict outcome in high-grade glioma during and after
postoperative radiotherapy. Anticancer Res 2011; 31: 3559–
3565.
47. Gupta K., Salunke P. Molecular markers of glioma: an update
on recent progress and perspectives. Journal of Cancer
Research and Clinical Oncology 2012, 138(12), 1971–1981.
http://doi.org/10.1007/s00432-012-1323-y48. Van den Bent M., Dubbink H., Marie Y., (). IDH1 and IDH2
mutations are prognostic but not predictive for outcome in
anaplastic oligodendroglial tumors: a report of the European
Organization for Research and Treatment of Cancer Brain
Tumor Group. Clinical Cancer Research: An Official Journal of
the American Association for Cancer Research, 2010; 16(5);
1597–1604.
http://doi.org/10.1158/1078-0432.CCR-09-2902
49. Carrillo J. A., Lai A., Nghiemphu P. Relationship between
tumor enhancement, edema, IDH1 mutational status, MGMT
promoter methylation, and survival in glioblastoma. AJNR.
American Journal of Neuroradiology 2012, 33(7), 1349–
1355.
http://doi.org/10.3174/ajnr.A295050. Ellingson B., Cloughesy T., Lai A., Nghiemphu P., Pope W. ().
Nonlinear registration of diffusion-weighted images improves
clinical sensitivity of functional diffusion maps in recurrent
glioblastoma treated with bevacizumab. Magnetic Resonance
in Medicine 2012; 67(1): 237–245.
http://doi.org/10.1002/mrm.23003
51. Jain R. Normalizing tumor microenvironment to treat cancer:
bench to bedside to biomarkers. Journal of Clinical Oncology:
Official Journal of the American Society of Clinical Oncology
2013;
31(17):
2205–2218.
http://doi.org/10.1200/JCO.2012.46.365.3
[EVALUACIÓN DE GLIOMAS POR TÉCNICAS AVANZADAS DE RESONANCIA MAGNÉTICA - Dra. Cecilia Okuma MD, PhD y col.]